Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 5.00 | 0.38% | 1,305.00 | 1,304.50 | 1,305.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1,309.50 | 1,300.00 | 1,300.00 | 274,638 | 08:46:43 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.01 | 53.89B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/11/2024 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
| 19/11/2024 | 09:24 | ALNC |  GSK hails positive results for linerixibat in treating relentless itch |
| 19/11/2024 | 07:00 | UK RNS | GSK PLC GLISTEN Trial of Linerixibat Meets Endpoint |
| 14/11/2024 | 08:54 | ALNC | GSK hails survival results in blood cancer patients with Blenrep |
| 14/11/2024 | 07:00 | UK RNS | GSK PLC GSK announces overall survival results for Blenrep |
| 13/11/2024 | 15:00 | UK RNS | GSK PLC Block listing Interim Review |
| 12/11/2024 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
| 11/11/2024 | 15:01 | UK RNS | GSK PLC GSK publishes provisional 2025 dividend dates |
| 04/11/2024 | 16:16 | ALNC | DIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sells |
| 01/11/2024 | 15:00 | UK RNS | GSK PLC Total Voting Rights |
1 Year Gsk Chart |
Intraday Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
